Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

長谷川香料

ADEKA

Otsuka Holdings

持田製薬

ONO PHARMACEUTICAL

The Nippon Synthetic Chemical Industry

アステラス製薬

Kuraray

Hitachi Chemical

Dainippon Sumitomo Pharma

MANDOM

キッセイ薬品工業

Mitsubishi Tanabe Pharma

ROHTO PHARMACEUTICAL

キョーリン製薬ホールディングス

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

クラリオン

クラリオン

クラリオン

クラリオン

メルコホールディングス

Financial Indicator Details: キョーリン製薬ホールディングス (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: キョーリン製薬ホールディングス (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	2.24% (-12.05%)	8.86% (-0.50%)	10.49% (1.53%)	8.94% (-1.67%)	11.60% (3.05%)
C/F margin (Industry Average)	5.03% (-3.31%)	12.05% (8.51%)	6.53% (7.04%)	8.63% (6.35%)	10.78% (8.25%)
ROA (Industry Average)	1.63% (0.52%)	6.44% (1.04%)	7.42% (2.07%)	6.33% (0.06%)	8.01% (2.71%)
ROE (Industry Average)	2.11% (-1.43%)	8.43% (0.03%)	9.78% (2.96%)	7.80% (4.68%)	9.62% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	8.71% (5.01%)	6.47% (2.61%)	5.81% (-0.40%)	9.21% (8.16%)
Sales growth (Industry Average)	- (-)	9.76% (-2.67%)	4.31% (5.36%)	-0.80% (1.07%)	3.68% (2.24%)
Net profit growth (Industry Average)	- (-)	334.36% (203.46%)	23.49% (63.25%)	-15.52% (3.89%)	34.56% (90.38%)
Operating C/F growth (Industry Average)	- (-)	162.88% (275.10%)	-43.41% (35.09%)	30.97% (-6.09%)	29.51% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	77.47% (53.80%)	76.47% (54.51%)	75.86% (55.00%)	81.14% (53.59%)	83.30% (56.30%)
Liquidity ratio (Industry Average)	346.02% (217.72%)	347.58% (225.70%)	343.27% (237.55%)	426.98% (239.89%)	472.83% (236.21%)
C/F ratio current liabilities (Industry Average)	474.64% (777.21%)	217.82% (303.31%)	447.03% (434.79%)	262.36% (929.73%)	198.34% (573.30%)
Quick ratio (Industry Average)	220.29% (138.97%)	217.77% (148.85%)	223.89% (156.17%)	285.14% (160.84%)	296.65% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	143.02day (83.89day)	134.85day (94.27day)	149.38day (93.96day)	159.34day (97.92day)	158.76day (98.27day)
Inventory turnover (Industry Average)	73.03day (54.45day)	80.02day (52.58day)	71.41day (52.64day)	73.32day (56.59day)	67.98day (58.68day)
Payable turnover (Industry Average)	33.16day (45.01day)	36.06day (49.82day)	38.06day (49.52day)	31.97day (52.10day)	29.17day (51.12day)
Working capita turnover (Industry Average)	182.89day (93.32day)	178.80day (97.02day)	182.74day (97.08day)	200.69day (102.41day)	197.57day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	10.63% (34.57%)	4.73% (1.49%)	10.66% (-3.85%)	46.65% (21.16%)
Dividend Yield (Industry Average)	0.94% (3.20%)	1.39% (1.93%)	3.51% (2.17%)	2.85% (2.45%)	1.94% (2.07%)
PER (Industry Average)	44.96% (25.22%)	11.45% (23.06%)	9.71% (16.22%)	12.72% (29.19%)	13.86% (16.58%)
PBR (Industry Average)	0.94% (0.86%)	0.96% (1.06%)	0.95% (1.04%)	0.99% (0.95%)	1.33% (1.08%)
PCFR (Industry Average)	20.01% (7.18%)	8.42% (9.23%)	15.59% (-2.43%)	13.17% (9.50%)	14.91% (7.56%)
PSR (Industry Average)	1.00% (0.77%)	1.01% (0.88%)	1.01% (1.10%)	1.13% (0.90%)	1.60% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	3.88% (-27.66%)	45.10% (-4.34%)	81.01% (-5.37%)	55.61% (-10.69%)	82.87% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	0.18% (0.52%)	3.29% (0.92%)	11.52% (1.42%)	3.78% (-0.27%)	13.02% (1.53%)
ROE (Industry Average)	0.18% (-0.84%)	3.31% (-0.46%)	11.60% (1.81%)	3.81% (3.42%)	13.08% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	1.58% (3.64%)	7.99% (3.03%)	0.04% (0.04%)	10.73% (3.91%)
Sales growth (Industry Average)	- (-)	57.68% (-3.48%)	110.76% (6.70%)	-52.11% (0.75%)	154.99% (-1.74%)
Net profit growth (Industry Average)	- (-)	1,728.66% (166.48%)	278.60% (43.48%)	-67.12% (-47.04%)	279.99% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	99.42% (56.79%)	99.40% (57.65%)	99.31% (57.17%)	99.33% (55.93%)	99.52% (57.57%)
Liquidity ratio (Industry Average)	107.43% (337.22%)	699.78% (276.75%)	1,504.80% (266.94%)	1,559.72% (314.47%)	3,205.57% (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	23.87% (167.28%)	501.48% (183.78%)	1,120.89% (174.83%)	1,409.38% (228.06%)	2,169.95% (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	- (87.55day)	- (98.39day)	- (95.88day)	- (98.58day)	- (67.18day)
Inventory turnover (Industry Average)	- (50.17day)	- (48.43day)	- (47.43day)	- (50.67day)	- (38.21day)
Payable turnover (Industry Average)	- (45.70day)	- (51.63day)	- (51.13day)	- (53.57day)	- (34.24day)
Working capita turnover (Industry Average)	- (92.02day)	- (95.19day)	- (92.19day)	- (95.69day)	- (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	10.63% (34.46%)	4.73% (3.11%)	10.66% (-3.30%)	46.65% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	610.57% (34.12%)	36.94% (27.80%)	10.21% (13.58%)	34.40% (22.26%)	13.27% (26.42%)
PBR (Industry Average)	1.12% (0.97%)	1.22% (1.21%)	1.18% (1.17%)	1.31% (1.08%)	1.73% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	23.74% (3.42%)	16.66% (4.34%)	8.27% (3.67%)	19.13% (4.37%)	11.00% (10.14%)

Financial Indicator Details: キョーリン製薬 HLDGS

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	2.24%	8.86%	10.49%	8.94%	11.60%
C/F margin	5.03%	12.05%	6.53%	8.63%	10.78%
ROA	1.63%	6.44%	7.42%	6.33%	8.01%
ROE	2.11%	8.43%	9.78%	7.80%	9.62%
Recurring margin	10.13%	14.26%	16.44%	14.79%	17.44%
EBIT margin	4.99%	13.74%	16.25%	14.66%	17.31%
EBITDA margin	9.17%	16.56%	18.62%	16.94%	19.87%
NOPAT margin	2.99%	8.24%	9.75%	8.79%	10.39%
Sales SG rates	40.47%	37.56%	36.08%	35.76%	37.49%
Sales SG&A rates	49.67%	49.14%	48.11%	50.21%	45.73%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	4.17%	2.81%	2.36%	2.28%	2.55%
Capital expenditures net sales ratio	-1.64%	-1.15%	-1.22%	-1.63%	-5.57%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	65.20%	26.37%	-15.29%	-1.13%
Equity growth	-	8.71%	6.47%	5.81%	9.21%
Total assets growth	-	10.14%	7.32%	-1.06%	6.38%
Sales growth	-	9.76%	4.31%	-0.80%	3.68%
Net profit growth	-	334.36%	23.49%	-15.52%	34.56%
Operating C/F growth	-	162.88%	-43.41%	30.97%	29.51%
Recurring profit growth	-	54.58%	20.20%	-10.72%	22.26%
EBIT growth	-	202.31%	23.35%	-10.55%	22.48%
EBITDA growth	-	98.24%	17.25%	-9.70%	21.59%
NOPAT growth	-	202.31%	23.35%	-10.55%	22.48%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	77.47%	76.47%	75.86%	81.14%	83.30%
Liquidity ratio	346.02%	347.58%	343.27%	426.98%	472.83%
C/F ratio current liabilities	474.64%	217.82%	447.03%	262.36%	198.34%
Quick ratio	220.29%	217.77%	223.89%	285.14%	296.65%
Fixed ratio	17.74%	15.08%	13.35%	12.30%	14.10%
D/E ratio	5.37%	3.23%	6.66%	2.93%	1.37%
Loan to Value Ratio	4.16%	2.47%	5.05%	2.38%	1.14%
Business investment C/F ratio	-32.74%	-9.58%	-18.72%	-18.91%	-51.73%
Liabilities with interest growth	-	-34.47%	119.16%	-53.32%	-48.94%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	49.08day	73.87day	89.49day	76.42day	72.87day
Receivables turnover	143.02day	134.85day	149.38day	159.34day	158.76day
Inventory turnover	73.03day	80.02day	71.41day	73.32day	67.98day
Fixed assets turnover	68.76day	57.89day	52.31day	51.42day	62.09day
Total asset turnover	500.18day	501.92day	516.39day	515.05day	528.47day
Payable turnover	33.16day	36.06day	38.06day	31.97day	29.17day
Capital turnover	2.81day	2.56day	2.45day	2.47day	2.38day
Equity turnover	387.53day	383.83day	391.78day	417.92day	440.25day
Working capita turnover	182.89day	178.80day	182.74day	200.69day	197.57day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 12 B	¥ 20 B	¥ 25 B	¥ 21 B	¥ 21 B
Accounts receivable-trade	¥ 35 B	¥ 36 B	¥ 42 B	¥ 45 B	¥ 46 B
Other Current Assets	¥ 62 B	¥ 70 B	¥ 78 B	¥ 78 B	¥ 86 B
Current Assets	¥ 75 B	¥ 91 B	¥ 104 B	¥ 99 B	¥ 108 B
Tangible Assets	¥ 17 B	¥ 15 B	¥ 14 B	¥ 14 B	¥ 18 B
Intangible Assets	¥ 1 B	¥ 1 B	¥ 816 M	¥ 846 M	¥ 916 M
Investment etc.	¥ 30 B	¥ 29 B	¥ 27 B	¥ 30 B	¥ 27 B
Total Assets	¥ 124 B	¥ 137 B	¥ 147 B	¥ 145 B	¥ 154 B
Current Liabilities	¥ 21 B	¥ 26 B	¥ 30 B	¥ 23 B	¥ 22 B
Fixed Liabilities	¥ 6 B	¥ 6 B	¥ 5 B	¥ 4 B	¥ 2 B
Liabilities with interest	¥ 5 B	¥ 3 B	¥ 7 B	¥ 3 B	¥ 1 B
Net Assets	¥ 96 B	¥ 104 B	¥ 111 B	¥ 118 B	¥ 129 B
Capital stock	¥ 700 M	¥ 700 M	¥ 700 M	¥ 700 M	¥ 700 M
Capital surplus etc.	¥ 95 B	¥ 104 B	¥ 111 B	¥ 117 B	¥ 128 B
Liabilities and net assets	¥ 124 B	¥ 137 B	¥ 147 B	¥ 145 B	¥ 154 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 90 B	¥ 99 B	¥ 104 B	¥ 103 B	¥ 107 B
Cost of Sales	¥ 36 B	¥ 37 B	¥ 37 B	¥ 36 B	¥ 40 B
Gross profit	¥ 54 B	¥ 62 B	¥ 66 B	¥ 66 B	¥ 66 B
Other income	¥ 1 B	¥ 1 B	¥ 910 M	¥ 901 M	¥ 815 M
SG&A	¥ 45 B	¥ 49 B	¥ 50 B	¥ 51 B	¥ 48 B
Other expenses	¥ 7 B	¥ 5 B	¥ 6 B	¥ 6 B	¥ 6 B
Net income	¥ 2 B	¥ 8 B	¥ 10 B	¥ 9 B	¥ 12 B
Operating income	¥ 8 B	¥ 13 B	¥ 16 B	¥ 14 B	¥ 17 B
Ordinary Income	¥ 9 B	¥ 14 B	¥ 17 B	¥ 15 B	¥ 18 B
EBITDA	¥ 8 B	¥ 16 B	¥ 19 B	¥ 17 B	¥ 21 B
Income before income taxes	¥ 4 B	¥ 13 B	¥ 17 B	¥ 15 B	¥ 18 B
Depreciation	¥ 3 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 2 B	¥ 5 B	¥ 6 B	¥ 6 B	¥ 6 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 4 B	¥ 12 B	¥ 6 B	¥ 8 B	¥ 11 B
Investment CF	¥ -4 B	¥ 412 M	¥ -1 B	¥ -4 B	¥ -7 B
Financial CF	¥ 1 B	¥ -3 B	¥ 201 M	¥ -7 B	¥ -5 B
Foreign Exchange Effects	¥ -305 M	¥ 50 M	¥ -93 M	¥ -29 M	¥ 108 M
Net Change in Cash	¥ 1 B	¥ 9 B	¥ 5 B	¥ -3 B	¥ -667 M
Free CF	¥ 346 M	¥ 12 B	¥ 4 B	¥ 3 B	¥ 4 B
Capital expenditures	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B	¥ -5 B
Cash dividends paid	¥ -863 M	¥ -1 B	¥ -3 B	¥ -3 B	¥ -3 B
Repayment loans	¥ -262 M	¥ -367 M	¥ -332 M	¥ -328 M	¥ -386 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -860 M	¥ -1 B	¥ -3 B	¥ -3 B	¥ -3 B
Net income	¥ 2 B	¥ 8 B	¥ 10 B	¥ 9 B	¥ 12 B
Purchase of treasury stock	¥ -65 M	¥ -33 M	¥ -21 M	¥ -13 M	¥ -4 M
Other Change in Stockholders Equity	¥ -1 M	-	¥ -1 M	¥ -2 M	¥ -1 M
Other Change in Net Assets	¥ -1 B	¥ 1 B	¥ -373 M	¥ 640 M	¥ 1 B
Net Change in Net Assets	¥ -683 M	¥ 8 B	¥ 6 B	¥ 6 B	¥ 10 B

Financial Indicator Details: キョーリン製薬 HLDGS

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	3.88%	45.10%	81.01%	55.61%	82.87%
C/F margin	-	-	-	-	-
ROA	0.18%	3.29%	11.52%	3.78%	13.02%
ROE	0.18%	3.31%	11.60%	3.81%	13.08%
Recurring margin	10.99%	58.81%	81.13%	57.38%	84.42%
EBIT margin	1.42%	46.00%	81.19%	57.25%	83.18%
EBITDA margin	1.42%	46.00%	81.19%	57.25%	83.18%
NOPAT margin	0.85%	27.60%	48.71%	34.35%	49.91%
Sales SG rates	63.41%	40.61%	19.16%	43.16%	15.81%
Sales SG&A rates	-	-	-	-	-
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	-	-	-	-	-
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	2,123.58%	186.76%	22.19%	22.43%
Equity growth	-	1.58%	7.99%	0.04%	10.73%
Total assets growth	-	1.60%	8.10%	0.01%	10.53%
Sales growth	-	57.68%	110.76%	-52.11%	154.99%
Net profit growth	-	1,728.66%	278.60%	-67.12%	279.99%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	743.63%	190.77%	-66.12%	275.13%
EBIT growth	-	4,987.27%	272.01%	-66.23%	270.46%
EBITDA growth	-	4,987.27%	272.01%	-66.23%	270.46%
NOPAT growth	-	4,987.27%	272.01%	-66.23%	270.46%
Operating expenses growth	-	¥ 98	¥ -52	¥ 785	¥ -656
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	99.42%	99.40%	99.31%	99.33%	99.52%
Liquidity ratio	107.43%	699.78%	1,504.80%	1,559.72%	3,205.57%
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	23.87%	501.48%	1,120.89%	1,409.38%	2,169.95%
Fixed ratio	0.37%	0.32%	0.24%	0.27%	0.87%
D/E ratio	-	-	-	-	-
Loan to Value Ratio	-	-	-	-	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	10.03day	141.45day	192.45day	491.04day	235.77day
Receivables turnover	-	-	-	-	-
Inventory turnover	-	-	-	-	-
Fixed assets turnover	28.67day	15.96day	6.29day	14.56day	20.30day
Total asset turnover	7,761.52day	5,001.07day	2,564.99day	5,356.92day	2,322.04day
Payable turnover	-	-	-	-	-
Capital turnover	66.24day	42.00day	19.93day	41.61day	16.32day
Equity turnover	7,717.23day	4,971.36day	2,547.36day	5,321.54day	2,310.96day
Working capita turnover	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 106 M	¥ 2 B	¥ 6 B	¥ 8 B	¥ 10 B
Accounts receivable-trade	-	-	-	-	-
Other Current Assets	¥ 371 M	¥ 932 M	¥ 2 B	¥ 881 M	¥ 4 B
Current Assets	¥ 477 M	¥ 3 B	¥ 9 B	¥ 9 B	¥ 14 B
Tangible Assets	¥ 303 M	¥ 266 M	¥ 221 M	¥ 245 M	¥ 871 M
Intangible Assets	¥ 90 M	¥ 88 M	¥ 167 M	¥ 198 M	¥ 512 M
Investment etc.	¥ 81 B	¥ 79 B	¥ 80 B	¥ 80 B	¥ 83 B
Total Assets	¥ 82 B	¥ 83 B	¥ 90 B	¥ 90 B	¥ 99 B
Current Liabilities	¥ 444 M	¥ 470 M	¥ 603 M	¥ 586 M	¥ 466 M
Fixed Liabilities	¥ 23 M	¥ 23 M	¥ 16 M	¥ 8 M	¥ 7 M
Liabilities with interest	-	-	-	-	-
Net Assets	¥ 81 B	¥ 82 B	¥ 89 B	¥ 89 B	¥ 99 B
Capital stock	¥ 700 M	¥ 700 M	¥ 700 M	¥ 700 M	¥ 700 M
Capital surplus etc.	¥ 80 B	¥ 82 B	¥ 88 B	¥ 88 B	¥ 98 B
Liabilities and net assets	¥ 82 B	¥ 83 B	¥ 90 B	¥ 90 B	¥ 99 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 3 B	¥ 6 B	¥ 12 B	¥ 6 B	¥ 15 B
Cost of Sales	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Gross profit	¥ 1 B	¥ 3 B	¥ 10 B	¥ 3 B	¥ 13 B
Other income	¥ 146 M	¥ 177 M	¥ 54 M	¥ 33 M	¥ 38 M
SG&A	-	-	-	-	-
Other expenses	¥ 1 B	¥ 1 B	¥ 30 M	¥ 108 M	¥ 242 M
Net income	¥ 150 M	¥ 2 B	¥ 10 B	¥ 3 B	¥ 12 B
Operating income	¥ 1 B	¥ 3 B	¥ 10 B	¥ 3 B	¥ 13 B
Ordinary Income	¥ 424 M	¥ 3 B	¥ 10 B	¥ 3 B	¥ 13 B
EBITDA	¥ 55 M	¥ 2 B	¥ 10 B	¥ 3 B	¥ 13 B
Income before income taxes	¥ 53 M	¥ 2 B	¥ 10 B	¥ 3 B	¥ 13 B
Depreciation	-	-	-	-	-
R&D expenses	-	-	-	-	-
Income taxes	¥ -96 M	¥ 55 M	¥ 24 M	¥ 101 M	¥ 57 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -860 M	¥ -1 B	¥ -3 B	¥ -3 B	¥ -3 B
Net income	¥ 150 M	¥ 2 B	¥ 10 B	¥ 3 B	¥ 12 B
Purchase of treasury stock	¥ -65 M	¥ -33 M	¥ -21 M	¥ -12 M	¥ -2 M
Other Change in Stockholders Equity	-	¥ -1 M	¥ -1 M	¥ -1 M	¥ -1 M
Other Change in Net Assets	¥ -35 M	-	-	-	-
Net Change in Net Assets	¥ -810 M	¥ 1 B	¥ 6 B	¥ 39 M	¥ 9 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: キョーリン製薬ホールディングス (Annual )

Statement Type

Annual : キョーリン製薬ホールディングス

First quarter : キョーリン製薬ホールディングス

Second quarter : キョーリン製薬ホールディングス

Third quarter : キョーリン製薬ホールディングス

Analysis Menu

Outline : キョーリン製薬ホールディングス

Statement : キョーリン製薬ホールディングス

Rating : キョーリン製薬ホールディングス

Indicator : キョーリン製薬ホールディングス

Download : キョーリン製薬ホールディングス

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo千代田区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
キョーリン製薬ホールディングス	4569	TSE 1st	Chemicals	3	Annual	A

Related Company

Sekisui Chemical (Sales ¥ 1.0 T)

Hitachi Chemical (Sales ¥ 464 B)

Mitsubishi Tanabe Pharma (Sales ¥ 419 B)

ROHTO PHARMACEUTICAL (Sales ¥ 129 B)

アステラス製薬 (Sales ¥ 1.0 T)

キッセイ薬品工業 (Sales ¥ 62 B)

Toray Industries (Sales ¥ 1.5 T)

東京応化工業 (Sales ¥ 72 B)

Dainippon Sumitomo Pharma (Sales ¥ 347 B)

MANDOM (Sales ¥ 60 B)

長谷川香料 (Sales ¥ 45 B)

Nissan Chemical Industries (Sales ¥ 153 B)

Nichi-Iko Pharmaceutical (Sales ¥ 93 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .